Anti-fibrotic treatments for chronic liver diseases: The present and the future
Naoshi Odagiri, Tsutomu Matsubara, Misako Sato-Matsubara, Hideki Fujii, Masaru Enomoto, Norifumi Kawada
Clin Mol Hepatol. 2021;27(3):413-424.   Published online 2020 Dec 3     DOI: https://doi.org/10.3350/cmh.2020.0187
Citations to this article as recorded by Crossref logo
The Fibrosis-5 Index Predicts Major Adverse Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
Senjiang Chen, Bouwei Zhu, Zan Luo, Yinchao Wang, Qingqing Hu, Liang Zhou
Angiology.2024;[Epub]     CrossRef
Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities, and Management of Non-alcoholic Fatty Liver Disorder
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin
Current Drug Therapy.2024; 19(1): 20.     CrossRef
An RORα agonist, ODH-08, inhibits fibrogenic activation of hepatic stellate cells via suppression of SMAD3
Haena Choi, Daehyun Oh, Hyeon-Ji Kim, Melody Chambugong, Mi-hyun Kim, Mi-Ock Lee, Hyeung-geun Park
Life Sciences.2024; 340: 122443.     CrossRef
TNFRSF12A mRNA Expression and Distribution of TNFRSF12A+ Cells in the Rate Liver during Thioacetamide-Induced Fibrogenesis
E. I. Lebedeva, A. T. Shchastniy, A. S. Babenka
Biology Bulletin.2024; 51(1): 11.     CrossRef
RNA-seq combined network pharmacology reveals that Fu-Gan-Wan (FGW) inhibits liver fibrosis via NF-κB/CCL2/CCR2 and lipid peroxidation via Nrf2/HMOX1 signaling pathway
Hanlin Shi, Xiaohong Duan, Jingcheng Dong, Yanyan Tao, Yang Lei
Journal of Ethnopharmacology.2024; 326: 117963.     CrossRef
Novel protein C6ORF120 promotes liver fibrosis by activating hepatic stellate cells through the PI3K/Akt/mTOR pathway
Xin Wang, Hui Liu, Yuqi Wang, Peng Wang, Yunyun Yi, Yingying Lin, Xin Li
Journal of Gastroenterology and Hepatology.2024;[Epub]     CrossRef
Diagnostic Efficacy of Serum Asialo α1-Acid Glycoprotein Levels for Advanced Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Compared to That in Healthy Subjects: A Prospective Study
Yoonseok Lee, Seryun Bae, Ji Hoon Kim, Minjung Kwak, So Yeon Jeon, Taehyung Kim, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun
Journal of Clinical Medicine.2023; 12(2): 712.     CrossRef
Association between Cardiovascular Disease and Liver Disease, from a Clinically Pragmatic Perspective as a Cardiologist
Mitsutaka Nakashima, Kazufumi Nakamura, Takahiro Nishihara, Keishi Ichikawa, Rie Nakayama, Yoichi Takaya, Norihisa Toh, Satoshi Akagi, Toru Miyoshi, Teiji Akagi, Hiroshi Ito
Nutrients.2023; 15(3): 748.     CrossRef
Pharmacological advances in the treatment of nonalcoholic fatty liver diseases : focused on global results of randomized controlled trials
Jihyun An, Joo Hyun Sohn
Clinical and Molecular Hepatology.2023; 29(Suppl): S268.     CrossRef
Immune microenvironment changes of liver cirrhosis: emerging role of mesenchymal stromal cells
Qiuyun Yi, Jinxian Yang, Ying Wu, Ying Wang, Qiqi Cao, Wen Wen
Frontiers in Immunology.2023;[Epub]     CrossRef
Hydronidone ameliorates liver fibrosis by inhibiting activation of hepatic stellate cells via Smad7‐mediated degradation of TGFβRI
Xianjun Xu, Yuecheng Guo, Xin Luo, Zhenyang Shen, Zhongshang Sun, Bo Shen, Cui Zhou, Junjun Wang, Jingyi Lu, Qingqing Zhang, Yanping Ye, Ying Luo, Ying Qu, Xiaobo Cai, Hui Dong, Lungen Lu
Liver International.2023; 43(11): 2523.     CrossRef
Hepatoprotective Effect of Medicine Food Homology Flower Saffron against CCl4-Induced Liver Fibrosis in Mice via the Akt/HIF-1α/VEGF Signaling Pathway
Huajuan Jiang, Xulong Huang, Jiaxin Wang, Yongfeng Zhou, Chaoxiang Ren, Tao Zhou, Jin Pei
Molecules.2023; 28(21): 7238.     CrossRef
Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches
Omima S. Mohammed, Hany G. Attia, Bassim M. S. A. Mohamed, Marawan A. Elbaset, Hany M. Fayed
Journal of Pharmacy & Pharmaceutical Sciences.2023;[Epub]     CrossRef
A Unique Immune-Related Gene Signature Represents Advanced Liver Fibrosis and Reveals Potential Therapeutic Targets
Pil-Soo Sung, Chang-Min Kim, Jung-Hoon Cha, Jin-Young Park, Yun-Suk Yu, Hee-Jung Wang, Jin-Kyeoung Kim, Si-Hyun Bae
Biomedicines.2022; 10(1): 180.     CrossRef
Stanniocalcin 1 is a serum biomarker and potential therapeutic target for HBV‐associated liver fibrosis
Kristy Kwan‐Shuen Chan, Tsz‐Chun Hon, Kwan‐Yung Au, Hiu‐Lam Choi, Danny Ka‐Ho Wong, Albert Chi‐Yan Chan, Man‐Fung Yuen, Ching‐Lung Lai, Regina Cheuk‐Lam Lo
The Journal of Pathology.2022; 257(2): 227.     CrossRef
The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities
Eleonora Binatti, Alessio Gerussi, Donatella Barisani, Pietro Invernizzi
International Journal of Molecular Sciences.2022; 23(12): 6649.     CrossRef
Treatment of Liver Fibrosis: A 20-Year Bibliometric and Knowledge-Map Analysis
Yun-Kai Dai, Zhi-Min Zhao, Chenghai Liu
Frontiers in Pharmacology.2022;[Epub]     CrossRef
The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathology
Youngseok Lee, Jong-Hoon Kim
Clinical and Molecular Hepatology.2022; 28(4): 706.     CrossRef
Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Michael H. Le, Yee Hui Yeo, Biyao Zou, Scott Barnet, Linda Henry, Ramsey Cheung, Mindie H. Nguyen
Clinical and Molecular Hepatology.2022; 28(4): 841.     CrossRef
Multiplexed Digital Spatial Protein Profiling Reveals Distinct Phenotypes of Mononuclear Phagocytes in Livers with Advanced Fibrosis
Jaejun Lee, Chang Min Kim, Jung Hoon Cha, Jin Young Park, Yun Suk Yu, Hee Jung Wang, Pil Soo Sung, Eun Sun Jung, Si Hyun Bae
Cells.2022; 11(21): 3387.     CrossRef
Hepatic HRC induces hepatocyte pyroptosis and HSCs activation via NLRP3/caspase-1 pathway
Jingwen Wu, Mingyu Zhang, Suhong Xia, Ping Han, Kai Zhao, Kaixin Peng, Wangdong Zhou, Dean Tian, Jiazhi Liao, Jingmei Liu
Journal of Molecular Medicine.2022; 100(12): 1787.     CrossRef
Myofibroblast specific targeting approaches to improve fibrosis treatment
Elfa Beaven, Raj Kumar, Himanshu N. Bhatt, Stephanie V. Esquivel, Md Nurunnabi
Chemical Communications.2022; 58(98): 13556.     CrossRef
Multiplexed Digital Spatial Protein Profiling Reveals a Unique Protein Signature for Advanced Liver Fibrosis
Jaejun Lee, Chang Min Kim, Jung Hoon Cha, Jin Young Park, Yun Suk Yu, Hee Jung Wang, Pil Soo Sung, Eun Sun Jung, Si Hyun Bae
SSRN Electronic Journal .2022;[Epub]     CrossRef
Protective Effect of Oligonol on Dimethylnitrosamine-Induced Liver Fibrosis in Rats via the JNK/NF-κB and PI3K/Akt/Nrf2 Signaling Pathways
Changyong Lee, Jeonghyeon Bak, Sik Yoon, Jeon-Ok Moon
Antioxidants.2021; 10(3): 366.     CrossRef